Aurora Kinase Inhibitors Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2015 - 2023.pdf

Aurora Kinase Inhibitors Market -Global Industry Analysis, Size,Share, Growth, Trends And Forecast2015 - 2023Single User License:USD 4315.5Flat 10% Discount!!Free Customization as per your requirementYou will get Custom Report at Syndicated ReportpriceReport will be delivered with in 15-20 working daysTransparency Market ResearchState Tower,90, State Street, Suite 700.Albany, NY 12207United Stateswww.transparencymarketresearch.comsales@transparencymarketresearch.comRequest SampleBuy Now

REPORT DESCRIPTIONThe Aurora kinases are enzymes which are crucial for cell proliferation. These enzymes are responsible for dividinggenetic material of the parent cell during the process of mitosis by controlling chromatid segregation. The defectrelated to this process is largely associated with cancer genesis in human body. In this way active involvement ofaurora kinase enzymes in initiating cancer genesis has lead considerable attention of therapists to their inhibition inthe work towards cancer treatment. There are three kind of aurora kinase found in human body namely A, B and C.Aurora C is mainly restricted to the process of spermatogenesis while remaining two are responsible varioustumerogenesis.http://www.transparencymarketresearch.com/aurora-kinase-inhibitors-Browse Full Report with TOC @market.htmlCancer is considered to the major causative factor for mortality worldwide with increasing incidence and prevalenceday by day. All regions of the world have seen continuous rise in number of cancer patients in past decade. WHOpredicted that annual cancer cases will reach to 19.3 million by 2025 from the 14.1 million annually in year 2012,whereas annual cases in 2008 were 12.7 million of which 1.7 million were women newly diagnosed with breastcancer that accounted for 20% in 2008. WHO mentions that cancer kills 8.2 millions globally out of which 522,000woman from breast cancer. It is mentionable that incidence rate is still higher in developed region whereas deathrates are higher in less developed countries. In all the cancer types, number of patients suffering with head andneck, gastrointestinal, breast and uterine cancer are highest.Aurora family Kinase Assay/Inhibitor screening kits are designed to estimate the inhibitory effect of individual Auroraactivity in the test chemical accurately. Merck Millipore, MBL International, Perkin Elmer, SignalChem are some of theleading companies which manufacture screening kits.Geographically North American region accounts for the largest market share in this market which is followed bydeveloping Asia Pacific market and European market. The market for Aurora Kinase inhibitor is driven by continuousincreasing number of cancer cases and improving healthcare standard outside the developed world andadvancements in early diagnosis of cancer. However there are restrictions such as high cost involved in drugdevelopment, lower spending capacity of poorer countries and need of real time clinical data. There are differentkind of biological therapies in oncology such as Tyrosine kinase inhibitor (includes erlotinib, imatinib, gefitinib,

dasatinib, sunitinib, ruxolitinib, etc.), monoclonal antibodies (includes trastuzumab, bevacizumab and cetuximab,etc.) whereas some are in development stage such as Aurora Kinase Inhibitor (Hesperadine, VX-680). Currently thereis no molecule is approved in this market however there are almost 30 molecules of Aurora Kinase inhibitor class indevelopment stage at different levels. With increase in cancer patients the market for Aurora Kinase Inhibitor marketis set to increase.Some of the major players in Aurora Kinase Inhibitor development market are Merck, Pfizer, Amgen, MillenniumPharmaceuticals, Cyclacel Pharmaceuticals, Bristol Myers Squibb. Along with these, there are companies such asRoche, Novartis, Eli Lilly, AstraZeneca, Celgene, Sanofi and GlaxoSmithKline have made their mark in oncology.This research report analyzes this market on the basis of its market segments, major geographies, andcurrent market trends. Geographies analyzed under this research report includeNorth AmericaAsia PacificEuropeMiddle East and AfricaLatin AmericaThis report provides comprehensive analysis ofMarket growth driversFactors limiting market growthCurrent market trendsMarket structureMarket projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. Itprovides market projections for the coming years. It includes analysis of recent developments intechnology, Porter’s five force model analysis and detailed profiles of top industry players. The report alsoincludes a review of micro and macro factors essential for the existing market players and new entrantsalong with detailed value chain analysis.Inquiry Before Buying: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4683Latest Press Release Reports: http://www.transparencymarketresearch.com/press-releases.htmLatest Articles Reports: http://www.transparencymarketresearch.com/articles.htmRead More Reports on Biotechnology Market:http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.htmlAbout UsTransparency Market Research (TMR) is a market intelligence company providing global business researchreports and consulting services. Our exclusive blend of quantitative forecasting and trends analysisprovides forward-looking insights for thousands of decision-makers.TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along withvarious tools and techniques to gather and analyze information. Our business offerings represent the latestand the most reliable information which is indispensable for businesses to sustain their competitive edge.

Contact:Transparency Market Research90 State Street,Suite 700,AlbanyNY - 12207United StatesTel: +1-518-618-1030USA - Canada Toll Free 866-552-3453Email: sales@transparencymarketresearch.comWebsite: http://www.transparencymarketresearch.com/